CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-26 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +9,574 | $58.06 | $556K | 39,917 |
| 2025-02-26 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −9,574 | $74.07 | $709K | 30,343 |
| 2025-02-26 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −4,495 | $74.08 | $333K | 25,848 |
| 2025-02-26 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −9,574 | 19,151 | ||
| 2025-01-31 | Morrissey Michael James EVP, Head of Tech. Operations | Grant or award | +10,552 | 81,515 | ||
| 2025-01-31 | Heeson Lee EVP, Head of Incyte Intl | Grant or award | +6,331 | 32,778 | ||
| 2025-01-21 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −12,352 | $72.69 | $898K | 66,967 |
| 2025-01-21 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −429 | $73.47 | $32K | 70,963 |
| 2025-01-17 | SWAIN PAULA J EVP, Human Resources | Grant or award · Employee Stock Option (right to buy) | +14,772 | 14,772 | ||
| 2025-01-17 | Iyengar Vijay K EVP, GMAPPS | Grant or award · Employee Stock Option (right to buy) | +14,772 | 14,772 | ||
| 2025-01-17 | Stamoulis Christiana EVP & Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +25,516 | 25,516 | ||
| 2025-01-17 | Flannelly Barry P EVP & General Manager US | Grant or award · Employee Stock Option (right to buy) | +20,144 | 20,144 | ||
| 2025-01-17 | Hoppenot Herve Chairman / CEO | Grant or award · Employee Stock Option (right to buy) | +55,510 | 55,510 | ||
| 2025-01-17 | Tray Thomas Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +3,432 | 3,432 | ||
| 2025-01-17 | CAGNONI PABLO J President, R&D | Grant or award · Employee Stock Option (right to buy) | +40,289 | 40,289 | ||
| 2025-01-17 | Denton Sheila A. EVP & General Counsel | Grant or award · Employee Stock Option (right to buy) | +12,086 | 12,086 | ||
| 2025-01-17 | Trotta Matteo EVP, GM, Dermatology US | Grant or award · Employee Stock Option (right to buy) | +5,371 | 5,371 | ||
| 2025-01-17 | Stein Steven H EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) 10b5-1 | +28,202 | 28,202 | ||
| 2025-01-15 | Flannelly Barry P EVP & General Manager US | Shares withheld for taxes | −3,158 | $72.46 | $229K | 53,374 |
| 2025-01-15 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −908 | $72.46 | $66K | 71,392 |
Page 23 of 25 · 500 trades